Drug
Lbh589
Lbh589: highest development phase Phase 1, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| LBH589 NCT00535951 | Phase 1 | Carcinoma, Non-Small-Cell Lung |
Latest
No recent events.
Follow Lbh589 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.